Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Clinical trial NCT05393986 · UNKNOWN

Trial details

NCT number: NCT05393986
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Pancreatic Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2022-08-04
Primary completion: 2023-06-30
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.